home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
Forum Page

Forum
Forum sources  
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
 

Restrictions in use of neonicotinoid-containing products is a set-back for European agriculture - Commission’s plan will not have a positive impact on bee health
Einschränkung des Einsatzes von neonikotinoidhaltigen Produkten ist ein Rückschlag für die europäische Landwirtschaft - Kommissionsplan wird sich nicht positiv auf die Bienengesundheit auswirken
As restrições impostas ao uso de produtos contendo neonicotinóides é um retrocesso para a agricultura europeia - O plano da Comissão não terá impacto positivo sobre a saúde das abelhas


Monheim, Germany
April 29, 2013

Bayer CropScience considers the decision by the Commission of the European Union to restrict the use of neonicotinoid-containing products across Europe as a set-back for technology, innovation and sustainability. In an Appeals Committee meeting today, only half of the EU Member States supported the Commission’s proposal for the restrictions. The company believes that the plan by the Commission will not have a positive impact on bee health.

The company is concerned that the restriction of these neonicotinoids will result in crop yield losses, reduced food quality and loss of competitiveness for European agriculture. This will have a negative impact on farmers, R&D driven ag companies, the seed industry and the food value chain.

As a science-based company, Bayer CropScience is disappointed that clear scientific evidence has taken a back-seat in the decision making process. This disproportionate decision is a missed opportunity to reach a solution that takes into consideration all of the existing product stewardship measures and broad stakeholder concerns. The further reduction of effective crop protection products will put at risk farmers’ ability to tackle important pests that can severely restrict their ability to grow high-quality food.

Bayer CropScience remains convinced that neonicotinoids are safe for bees, when used responsibly and properly, according to label instructions. The company will work together with all relevant stakeholders and authorities in the Member States to handle the complex consequences of this decision, to further support its customers.

More information on the Bayer Bee Care program can be found at http://www.beecare.bayer.com.

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. This year the company looks back on 150 years of working to fulfill its mission "Bayer: Science For A Better Life". Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,383 million (2012) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 20,800 and is represented in more than 120 countries.


Einschränkung des Einsatzes von neonikotinoidhaltigen Produkten ist ein Rückschlag für die europäische Landwirtschaft - Kommissionsplan wird sich nicht positiv auf die Bienengesundheit auswirken

Bayer CropScience hält die Entscheidung der Europäischen Kommission, den Einsatz einer Reihe von neonikotinoidhaltigen Produkten in Europa einzuschränken, für einen Rückschlag für Technologie, Innovation und Nachhaltigkeit. In einer Sitzung des Berufungsausschusses der EU hatte lediglich die Hälfte der Mitgliedsstaaten den Vorschlag der Kommission unterstützt. Das Unternehmen glaubt nicht, dass der Plan der Kommission sich positiv auf die Bienengesundheit auswirken wird.

Das Unternehmen befürchtet, dass die Nutzungseinschränkung von Neonikotinoiden für die europäische Landwirtschaft zu mehr Pflanzenschäden, höheren Ernteausfällen, einer verminderten Lebensmittelqualität und einem Verlust an Wettbewerbsfähigkeit führt.

Als forschendes Unternehmen ist Bayer CropScience enttäuscht, dass eindeutige wissenschaftliche Nachweise bei diesem Entscheidungsfindungsprozess in den Hintergrund gerückt sind. Mit diesem unverhältnismäßigen Entschluss wurde eine Chance verpasst, eine Lösung zu finden, die alle vorhandenen Stewardship-Maßnahmen berücksichtigt und die Bedenken aller Stakeholder ernst nimmt. Die weitere Reduzierung von effektiven Pflanzenschutzprodukten gefährdet die Möglichkeit der Landwirte, wichtige Schädlinge zu bekämpfen und kann den Anbau hochwertiger Nahrungsmittel empfindlich beeinträchtigen.

Bayer CropScience ist auch weiterhin überzeugt, dass Neonikotinoide für Bienen sicher sind, wenn die Produkte verantwortungsvoll und vorschriftsmäßig eingesetzt werden. Das Unternehmen wird mit allen beteiligten Interessenvertretern und den Behörden der Mitgliedstaaten zusammenarbeiten, um mit den komplexen Konsequenzen dieser Entscheidung umzugehen und seine Kunden weiter zu unterstützen.

Mehr Informationen zum kontinuierlichen Engagement von Bayer für die Bienengesundheit finden Sie auf http://www.beecare.bayer.com


As restrições impostas ao uso de produtos contendo neonicotinóides é um retrocesso para a agricultura europeia - O plano da Comissão não terá impacto positivo sobre a saúde das abelhas

A Bayer CropScience considera a decisão da Comissão da União Europeia de restringir o uso de produtos contendo neonicotinóides em toda a Europa um retrocesso para a tecnologia, inovação e para a sustentabilidade. Em uma reunião do Comitê de Apelação realizada hoje, apenas metade dos Estados-Membros da UE apoiou a proposta da Comissão relativa às restrições. A empresa acredita que o plano da Comissão não terá impacto positivo na saúde das abelhas.

 

A empresa se preocupa que a restrição imposta nesses neonicotinóides resultará em perdas de rendimento dos cultivos, na redução da qualidade dos alimentos e na perda de competitividade para a agricultura europeia. Isto terá impacto negativo para os agricultores, empresas agrícolas que focam em P&D, para o setor de sementes e na cadeia de valor alimentar.

 

Como uma empresa baseada na ciência, a Bayer CropScience está decepcionada com o fato de que as claras evidências científicas ficaram em segundo plano no processo de tomada de decisão. Esta decisão desproporcional é uma oportunidade perdida para que se alcance uma solução que leve em consideração todas as medidas de manejo de produtos existentes e as amplas preocupações das partes interessadas. A redução ainda maior na disponibilidade de produtos eficazes de proteção de cultivos colocará em risco a capacidade dos agricultores para enfrentar as pragas destrutivas que podem severamente restringir sua capacidade de produzir alimentos de alta qualidade.

 

A Bayer CropScience continua convencida de que os neonicotinóides são seguros para as abelhas quando utilizados de forma responsável e corretamente, de acordo com as instruções do rótulo. A empresa trabalhará em conjunto com todas as partes interessadas e autoridades dos Estados-Membros para lidar com as consequências desta decisão de forma a apoiar aos seus clientes.


 



More news from: Bayer CropScience AG


Website: http://www.bayercropscience.com

Published: April 29, 2013



SeedQuest does not necessarily endorse the factual analyses and opinions
presented on this Forum, nor can it verify their validity.

 

 

 

 

 

 

 

 

 

 


Copyright @ 1992-2024 SeedQuest - All rights reserved